Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1734108 | 1.00 | CA1 (0.30) | CA1CA2CA4 | |
| SCHEMBL1734110 | 1.00 | CA1 (0.30) | CA1CA2CA4 | |
| SCHEMBL1734982 | 0.95 | — | — | |
| SCHEMBL1734984 | 0.95 | — | — | |
| SCHEMBL1734007 | 0.89 | — | — | |
| SCHEMBL1734006 | 0.89 | — | — | |
| SCHEMBL2013433 | 0.83 | — | — | |
| SCHEMBL2013432 | 0.83 | — | — | |
| SCHEMBL3685985 | 0.81 | — | — | |
| SCHEMBL4121863 | 0.79 | CYP1A2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957198-B1 | CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INT UK LTD (GB) | 2018-08-22 | — | — | EP | disclosed |
| US-9334227-B2 | Carbonylation of ethylenically unsaturated compounds | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-05-10 | — | — | US | disclosed |
| US-20090163724-A1 | Carbonylation of Ethylenically Unsaturated Compounds | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163724-A1 | Carbonylation of Ethylenically Unsaturated Compounds | CBR3, ETFA, ACOX3 | CA1 905/4885CA2 916/4885CA4 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.